Work

Proton pump inhibitor use (PPI) in patients treated with immune checkpoint inhibitors (ICI) for advanced cancer: Survival and prior therapy.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.15_suppl.2633

Authors: Marium Husain, Menglin Xu, Sandipkumar Patel, Andrew Johns, Madison Grogan, Mingjia Li, Gabrielle Lopez, Abdul Miah, Rebecca Hoyd, YunZhou Liu, Mitchell Muniak, Tyler Haddad, Gabriel Tinoco, Kari Lynn Kendra, Gregory Alan Otterson, Carolyn J Presley, Daniel Spakowicz, Dwight Hall Owen

Institutions: The Ohio State University Wexner Medical Center, The Ohio State University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W3166116346

Cites:

Cited by: 11

Related to: 10